Determining patient eligibility is one of the most time-intensive and expensive processes in clinical trials. Not only do traditional practices include gathering detailed, paper-based patient information to determine if a patient is eligible to participate, but outdated tracking systems are prone to costly errors. But a significant shift is underway as inclusion and exclusion criteria…